173 related articles for article (PubMed ID: 35117397)
1. Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection.
Wang T; Wang N; Zhou H; Zhou A; Jin J; Chen Y; Zhao D
Transl Cancer Res; 2020 Feb; 9(2):529-535. PubMed ID: 35117397
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of immunotherapy plus chemotherapy as neoadjuvant treatment for patients with locally advanced gastric cancer: a retrospective cohort study.
Wang X; Huang J; Huang H; Liu Y; Ji C; Liu J
Invest New Drugs; 2023 Aug; 41(4):579-586. PubMed ID: 37368088
[TBL] [Abstract][Full Text] [Related]
3. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
4. The Effect of Neoadjuvant Therapies for Patients with Locally Advanced Gastric Cancer: A Propensity Score Matching Study.
Wang T; Chen Y; Zhao L; Zhou H; Wu C; Zhang X; Zhou A; Jin J; Zhao D
J Cancer; 2021; 12(2):379-386. PubMed ID: 33391434
[No Abstract] [Full Text] [Related]
5. Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new?
Rosa F; Laterza V; Schena CA; Tondolo V; Strippoli A; Covino M; Pacini G; Quero G; Fiorillo C; DE Sio D; Tortora G; Alfieri S
Minerva Surg; 2023 Oct; 78(5):481-489. PubMed ID: 37283508
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs . chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study.
Xu G; Liu T; Shen J; Guan Q
Chin Med J (Engl); 2024 Feb; ():. PubMed ID: 38420853
[TBL] [Abstract][Full Text] [Related]
7. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy.
Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.
Huang Z; Li S; Yang X; Lu F; Huang M; Zhang S; Xiong Y; Zhang P; Si J; Ma Y; Yang Y
Cancer Manag Res; 2019; 11():1299-1308. PubMed ID: 30799956
[TBL] [Abstract][Full Text] [Related]
9. Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Luangdilok S; Samarnthai N; Korphaisarn K
J Breast Cancer; 2014 Dec; 17(4):376-85. PubMed ID: 25548587
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy.
Guo F; Xiang X; Huang Y; Chen A; Ma L; Zhu X; Abdulla Z; Jiang W; Li J; Li G
Int J Clin Oncol; 2023 Sep; 28(9):1158-1165. PubMed ID: 37318644
[TBL] [Abstract][Full Text] [Related]
11. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
12. Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma.
Wang Z; He T; Yu D; Qin X; Geng A; Yang H
Exp Ther Med; 2022 Oct; 24(4):625. PubMed ID: 36160880
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study.
Wang X; Zhao DB; Yang L; Chi Y; Zhao H; Jiang LM; Jiang J; Tang Y; Li N; Liu WY; Dou LZ; Zou SM; Xue LY; Ren JS; Tian YT; Che X; Guo CG; Bai XF; Sun YM; Wang SL; Song YW; Liu YP; Fang H; Li YX; Jin J
Front Oncol; 2022; 12():870741. PubMed ID: 35574368
[TBL] [Abstract][Full Text] [Related]
14. Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis.
Eom BW; Kim S; Kim JY; Yoon HM; Kim MJ; Nam BH; Kim YW; Park YI; Park SR; Ryu KW
J Gastric Cancer; 2018 Mar; 18(1):69-81. PubMed ID: 29629222
[TBL] [Abstract][Full Text] [Related]
15. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
16. Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy.
Li CC; Yeh YS; Chen YC; Su WC; Chang TK; Tsai HL; Huang CW; Ma CJ; Yin TC; Chen PJ; Wang JY
J Oncol; 2022; 2022():3719241. PubMed ID: 35345514
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
18. Open vs. laparoscopic surgery for locally advanced gastric cancer after neoadjuvant therapy: Short-term and long-term survival outcomes.
Wang N; Zhou A; Jin J; Huang H; Zhang Y; Chen Y; Zhao D
Oncol Lett; 2020 Jul; 20(1):861-867. PubMed ID: 32566013
[TBL] [Abstract][Full Text] [Related]
19. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
20. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection.
Dossa F; Acuna SA; Rickles AS; Berho M; Wexner SD; Quereshy FA; Baxter NN; Chadi SA
JAMA Oncol; 2018 Jul; 4(7):930-937. PubMed ID: 29710274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
